Scientists at SUNY Downstate Medical Center in Brooklyn and Peking University in Beijing have received a U.S. patent for their virtual telemicroscope. This software may be used by offsite pathologists to diagnose diseases in patients located elsewhere. Chinese company Motic has used the patent to create a microscope that scans the slides at different magnifications and the compressed images produced thereafter are emailed to various required locations.

Aerocrine AB has filed a patent infringement suit against Medisoft P.A.E. associated with the marketing and sale of Nitric Oxide (NO) analyser in Germany. Aerocrine AB is seeking an injunction and damages against the Belgian company. Medisoft P.A.E. has recently begun the marketing and sale of the Hypair exhaled NO analyzer in the country.

Abviva Inc. (formerly known as Genesis Bioventures) has been issued a pivotal patent by the United States Patent and Trademark Office for the core technology used in the company’s breast cancer diagnostic test. The Mammastatin Serum Assay (MSA) is a blood test used for the early detection of breast cancer through the identification and measurement of the amount of Mammastatin in women.

Barr Pharmaceuticals Inc. has been granted patent protection by the FDA for its extended cycle oral contraceptive, Seasonique. The patent would run through January 30, 2024. Seasonique, which was approved by the FDA in May 2006, is a birth control pill that limits menstrual cycles to four in a year. The regimen comprises of taking active contraceptive pills daily for 84 days, followed by 7 days of a low dose of estrogen.